Skip to content
Search

Latest Stories

RPS welcomes govt proposal to increase access to PrEP via community pharmacies in Wales

The Royal Pharmaceutical Society (RPS) Wales has welcomed proposals from the Welsh government to increase access to PrEP via community pharmacies for people at risk of HIV.

The new HIV Action Plan for Wales consultation proposes a shared care model between primary care and specialist sexual health services to improve access to PrEP.


Commenting on the proposal, chair of RPS in Wales Cheryl Way said: “Increasing access to the medicines has been a long-standing issue of concern for us at RPS and we’re therefore delighted to see the proposals outlined by the Welsh government to develop a model which will enable PrEP to be provided by community pharmacies across Wales.

“PrEP are highly effective medicines, that reduce the chances of getting HIV, as proven by the Welsh Government’s three year PrEPARED study which found no new diagnoses of HIV among over 1,200 people taking PrEP in Wales. This is clear evidence that PrEP should be made as easily accessible as possible to those who need it.

“Community pharmacists and their teams are trusted and accessible health professionals. They will undoubtedly be a great additional asset in extending reach beyond the sexual health clinics already in place that are supplying PrEP. This will especially be the case for many in rural areas and groups who traditionally avoid such clinics.

On World Aids Day last year,  RPS called for PrEP to be more widely available through community pharmacies for those who need it.

Cheryl added: “We encourage the Westminster Government to act so that access to this highly effective medicine is extended further to those who would benefit from it."

More For You

NHS to roll out RSV vaccinations across 200 pharmacies in 2025/26

NHS England aims to ensure that everyone aged 75 to 79 years old is offered RSV vaccination by 31 August 2025.

Photo credit: gettyimages

RSV vaccination pilot to expand to 200 pharmacies in 2025/26

As part of its public health functions for 2025/26, NHS England plans to expand the Respiratory Syncytial Virus (RSV) immunisation programme to include up to 200 community pharmacies in targeted areas.

This follows the launch of an early adopter initiative in September 2024, where 50 community pharmacy sites in the East of England were commissioned to offer RSV vaccinations.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less